388 related articles for article (PubMed ID: 23419831)
1. APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.
Ramanan VK; Risacher SL; Nho K; Kim S; Swaminathan S; Shen L; Foroud TM; Hakonarson H; Huentelman MJ; Aisen PS; Petersen RC; Green RC; Jack CR; Koeppe RA; Jagust WJ; Weiner MW; Saykin AJ;
Mol Psychiatry; 2014 Mar; 19(3):351-7. PubMed ID: 23419831
[TBL] [Abstract][Full Text] [Related]
2. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
Fleisher AS; Chen K; Liu X; Roontiva A; Thiyyagura P; Ayutyanont N; Joshi AD; Clark CM; Mintun MA; Pontecorvo MJ; Doraiswamy PM; Johnson KA; Skovronsky DM; Reiman EM
Arch Neurol; 2011 Nov; 68(11):1404-11. PubMed ID: 21747008
[TBL] [Abstract][Full Text] [Related]
3. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal evaluation of a novel BChE PET tracer as an early
Rejc L; Gómez-Vallejo V; Joya A; Moreno O; Egimendia A; Castellnou P; Ríos-Anglada X; Cossío U; Baz Z; Passannante R; Tobalina-Larrea I; Ramos-Cabrer P; Giralt A; Sastre M; Capetillo-Zarate E; Košak U; Knez D; Gobec S; Marder M; Martin A; Llop J
Theranostics; 2021; 11(13):6542-6559. PubMed ID: 33995675
[No Abstract] [Full Text] [Related]
5. APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points.
Toledo JB; Habes M; Sotiras A; Bjerke M; Fan Y; Weiner MW; Shaw LM; Davatzikos C; Trojanowski JQ;
J Alzheimers Dis; 2019; 69(3):783-793. PubMed ID: 31127775
[TBL] [Abstract][Full Text] [Related]
6. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
[TBL] [Abstract][Full Text] [Related]
7. Association between tau deposition and antecedent amyloid-β accumulation rates in normal and early symptomatic individuals.
Tosun D; Landau S; Aisen PS; Petersen RC; Mintun M; Jagust W; Weiner MW;
Brain; 2017 May; 140(5):1499-1512. PubMed ID: 28334939
[TBL] [Abstract][Full Text] [Related]
8. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
[TBL] [Abstract][Full Text] [Related]
9. APOE and AβPP gene variation in cortical and cerebrovascular amyloid-β pathology and Alzheimer's disease: a population-based analysis.
Peuralinna T; Tanskanen M; Mäkelä M; Polvikoski T; Paetau A; Kalimo H; Sulkava R; Hardy J; Lai SL; Arepalli S; Hernandez D; Traynor BJ; Singleton A; Tienari PJ; Myllykangas L
J Alzheimers Dis; 2011; 26(2):377-85. PubMed ID: 21654062
[TBL] [Abstract][Full Text] [Related]
10. Association of plasma and cortical amyloid beta is modulated by APOE ε4 status.
Swaminathan S; Risacher SL; Yoder KK; West JD; Shen L; Kim S; Inlow M; Foroud T; Jagust WJ; Koeppe RA; Mathis CA; Shaw LM; Trojanowski JQ; Soares H; Aisen PS; Petersen RC; Weiner MW; Saykin AJ;
Alzheimers Dement; 2014 Jan; 10(1):e9-e18. PubMed ID: 23541187
[TBL] [Abstract][Full Text] [Related]
11. Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth.
Murphy KR; Landau SM; Choudhury KR; Hostage CA; Shpanskaya KS; Sair HI; Petrella JR; Wong TZ; Doraiswamy PM;
Neuroimage; 2013 Sep; 78():474-80. PubMed ID: 23624169
[TBL] [Abstract][Full Text] [Related]
12. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
[TBL] [Abstract][Full Text] [Related]
13. Topographical APOE ɛ4 Genotype Influence on Cerebral Metabolism in the Continuum of Alzheimer's Disease: Amyloid Burden Adjusted Analysis.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Alzheimers Dis; 2016 Sep; 54(2):559-68. PubMed ID: 27567846
[TBL] [Abstract][Full Text] [Related]
14. Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease.
Macdonald IR; Maxwell SP; Reid GA; Cash MK; DeBay DR; Darvesh S
J Alzheimers Dis; 2017; 58(2):491-505. PubMed ID: 28453492
[TBL] [Abstract][Full Text] [Related]
15. Amyloid Deposition Is Greater in Cerebral Gyri than in Cerebral Sulci with Worsening Clinical Diagnosis Across the Alzheimer's Disease Spectrum.
Walden LM; Hu S; Madabhushi A; Prescott JW;
J Alzheimers Dis; 2021; 83(1):423-433. PubMed ID: 34334397
[TBL] [Abstract][Full Text] [Related]
16. Regional brain hypometabolism is unrelated to regional amyloid plaque burden.
Altmann A; Ng B; Landau SM; Jagust WJ; Greicius MD;
Brain; 2015 Dec; 138(Pt 12):3734-46. PubMed ID: 26419799
[TBL] [Abstract][Full Text] [Related]
17. Florbetapir PET-assessed demyelination is associated with faster tau accumulation in an APOE ε4-dependent manner.
Rubinski A; Dewenter A; Zheng L; Franzmeier N; Stephenson H; Deming Y; Duering M; Gesierich B; Denecke J; Pham AV; Bendlin B; Ewers M;
Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1035-1049. PubMed ID: 38049659
[TBL] [Abstract][Full Text] [Related]
18. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
[TBL] [Abstract][Full Text] [Related]
19. Estimation of amyloid distribution by [
Thal DR; Beach TG; Zanette M; Lilja J; Heurling K; Chakrabarty A; Ismail A; Farrar G; Buckley C; Smith APL
Acta Neuropathol; 2018 Oct; 136(4):557-567. PubMed ID: 30123935
[TBL] [Abstract][Full Text] [Related]
20. Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.
Chung JK; Plitman E; Nakajima S; Chakravarty MM; Caravaggio F; Gerretsen P; Iwata Y; Graff-Guerrero A;
J Geriatr Psychiatry Neurol; 2016 May; 29(3):149-59. PubMed ID: 26400248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]